Byrne Lee, MD FACS

4.8/5

Biography

Dr. Lee is a native of New York City. He attended the Sophie Davis School of Biomedical Education at the City College of New York and received his medical degree from New York Medical College. He completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at the City of Hope National Cancer Center. Dr. Lee led the Peritoneal Surface Malignancy Program at City of Hope prior to joining Stanford in 2019.

Dr. Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has dedicated his clinical practice to the surgical management of metastatic disease, particularly to the liver and peritoneum. He has expertise in delivering regional cancer therapies such as heated intraperitoneal chemotherapy (HIPEC). Additionally, he performs surgery for cancers of the stomach, liver, pancreas, small intestine, colon, and soft tissue sarcoma. He utilizes minimally invasive and robotic surgical techniques when appropriate.

Dr. Lee leads the Regional Cancer Therapies program at Stanford. The program implements and develops novel treatment strategies for patients affected with peritoneal malignancies and oligometastatic disease to the liver. His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary, and peritoneal surface malignancies. He is a member of a national consensus group performing collaborative research and developing clinical trials for HIPEC surgeries.

View Full Biography

Professional Summary

Education & Certifications

Medical Education: New York Medical College Registrar (2000) NY
Fellowship: City of Hope Surgical Oncology Fellowship (2007) CA
Board Certification: American Board of Surgery, General Surgery (2006)
- Residency: Lenox Hill Hospital General Surgery Residency (2005) NY

View More Education & Certifications

Honors & Awards

Top Doctors, Los Angeles Magazine (2017-2019)

Administrative Appointments

Director, Regional Cancer Therapies, Stanford University (2019 - Present)

Publications

Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
Whealon, M. D., Gahagan, J. V., Sujatha-Bhaskar, S., O'Leary, M. P., Selleck, M., Dumitra, S., … Pigazzi, A. (2017). Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)? Annals of Surgical Oncology, 24(8), 2122–28.
Multivisceral robotic liver surgery: feasible and safe.
Konstantinidis, I. T., Raoof, M., Zheleva, V., Lafaro, K., Lau, C., Fong, Y., & Lee, B. (2019). Multivisceral robotic liver surgery: feasible and safe. Journal of Robotic Surgery.
Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis.
Raoof, M., Blakely, A. M., Melstrom, L. G., Lee, B., Warner, S. G., Chung, V., … Fong, Y. (2019). Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis. Cancer Medicine.
- Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine Tumors.
  Blakely, A., Lafaro, K., Li, D., Kessler, J., Chang, S., Ituarte, P., … Singh, G. (2019). Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine Tumors. Neuroendocrinology.
- Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative.
  Gamboa, A. C., Zaidi, M. Y., Lee, R. M., Speegle, S., Switchenko, J. M., Lipscomb, J., … Maithel, S. K. (2019). Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Annals of Surgical Oncology.
- ASO Author Reflections: A Novel Tool to Assess and Describe HIPEC Complications.
  Dumitra, S., & Lee, B. (2019). ASO Author Reflections: A Novel Tool to Assess and Describe HIPEC Complications. Annals of Surgical Oncology.
- Prognostic significance of Chromogranin A in small pancreatic neuroendocrine tumors.
  Raoof, M., Jutric, Z., Melstrom, L. G., Lee, B., Li, D., Warner, S. G., … Singh, G. (2019). Prognostic significance of Chromogranin A in small pancreatic neuroendocrine tumors. Surgery, 165(4), 760–66.
- Hypothermia Is Associated with Surgical Site Infection in Cytoreductive Surgery with Hyperthermic Intra-Peritoneal Chemotherapy.
  Eng, O. S., Raoof, M., O'Leary, M. P., Lew, M. W., Wakabayashi, M. T., Paz, I. B., … Lee, B. (2018). Hypothermia Is Associated with Surgical Site Infection in Cytoreductive Surgery with Hyperthermic Intra-Peritoneal Chemotherapy. Surgical Infections, 19(6), 618–21.
- A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
  Eng, O. S., Raoof, M., Blakely, A. M., Yu, X., Lee, S. J., Han, E. S., … Dellinger, T. H. (2018). A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer. Journal of Surgical Oncology, 118(1), 121–26.
- Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival with or without Liver Treatment.
  Lewis, A., Raoof, M., Ituarte, P. H., Williams, J., Melstrom, L., Li, D., … Singh, G. (2018). Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival with or without Liver Treatment. Annals of Surgery.
- The Comprehensive Complication Index: a New Measure of the Burden of Complications After Hyperthermic Intraperitoneal Chemotherapy.
  Dumitra, S., O'Leary, M., Raoof, M., Wakabayashi, M., Dellinger, T. H., Han, E. S., … Lee, B. (2018). The Comprehensive Complication Index: a New Measure of the Burden of Complications After Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology, 25(3), 688–93.
- Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative.
  Zaidi, M. Y., Lee, R. M., Gamboa, A. C., Speegle, S., Cloyd, J. M., Kimbrough, C., … Staley, C. A. (2019). Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. Annals of Surgical Oncology.
- Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
  Kotha, N. V., Baumgartner, J. M., Veerapong, J., Cloyd, J. M., Ahmed, A., Grotz, T. E., … Kelly, K. J. (2019). Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. Annals of Surgical Oncology, 26(7), 2234–40.
- Enhanced Recovery after Surgery for Gastric Cancer Patients Improves Clinical Outcomes at a US Cancer Center.
  Desiderio, J., Stewart, C. L., Sun, V., Melstrom, L., Warner, S., Lee, B., … Woo, Y. (2018). Enhanced Recovery after Surgery for Gastric Cancer Patients Improves Clinical Outcomes at a US Cancer Center. Journal of Gastric Cancer, 18(3), 230–41.
- Robotic total pancreatectomy with splenectomy: technique and outcomes.
  Konstantinidis, I. T., Jutric, Z., Eng, O. S., Warner, S. G., Melstrom, L. G., Fong, Y., … Singh, G. (2018). Robotic total pancreatectomy with splenectomy: technique and outcomes. Surgical Endoscopy, 32(8), 3691–96.
- Frailty Correlates with Postoperative Mortality and Major Morbidity After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
  Konstantinidis, I. T., Chouliaras, K., Levine, E. A., Lee, B., & Votanopoulos, K. I. (2017). Frailty Correlates with Postoperative Mortality and Major Morbidity After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology, 24(13), 3825–30.
- Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
  Eng, O. S., Dumitra, S., O'Leary, M., Raoof, M., Wakabayashi, M., Dellinger, T. H., … Lee, B. (2017). Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy. JAMA Surgery, 152(12), 1156–60.
- Robotic Total Pelvic Exenteration: Video-Illustrated Technique.
  Konstantinidis, I. T., Chu, W., Tozzi, F., Lau, C., Wakabayashi, M., Chan, K., & Lee, B. (2017). Robotic Total Pelvic Exenteration: Video-Illustrated Technique. Annals of Surgical Oncology, 24(11), 3422–23.
- Mesenteric Lymphadenectomy in Well-Differentiated Appendiceal Neuroendocrine Tumors.
  Raoof, M., Dumitra, S., O'Leary, M. P., Singh, G., Fong, Y., & Lee, B. (2017). Mesenteric Lymphadenectomy in Well-Differentiated Appendiceal Neuroendocrine Tumors. Diseases of the Colon and Rectum, 60(7), 674–81.
- Wireless Monitoring Program of Patient-Centered Outcomes and Recovery Before and After Major Abdominal Cancer Surgery.
  Sun, V., Dumitra, S., Ruel, N., Lee, B., Melstrom, L., Melstrom, K., … Fong, Y. (2017). Wireless Monitoring Program of Patient-Centered Outcomes and Recovery Before and After Major Abdominal Cancer Surgery. JAMA Surgery, 152(9), 852–59.
- Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
  Eng, O. S., Dumitra, S., O'Leary, M., Wakabayashi, M., Dellinger, T. H., Han, E. S., … Lee, B. (2017). Base Excess as a Predictor of Complications in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology, 24(9), 2707–11.
- Minimally invasive distal pancreatectomy: greatest benefit for the frail.
  Konstantinidis, I. T., Lewis, A., Lee, B., Warner, S. G., Woo, Y., Singh, G., … Melstrom, L. G. (2017). Minimally invasive distal pancreatectomy: greatest benefit for the frail. Surgical Endoscopy, 31(12), 5234–40.
- Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.
  Woo, Y., Goldner, B., Ituarte, P., Lee, B., Melstrom, L., Son, T., … Hyung, W. J. (2017). Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study. Journal of the American College of Surgeons, 224(4), 546–55.
- Lymphovascular Invasion Predicts Lymph Node Involvement in Small (< 2 cm) Appendiceal Neuroendocrine Tumors
  Blakely, A. M., Raoof, M., Ituarte, P. H. G., Singh, G., & Lee, B. (2018). Lymphovascular Invasion Predicts Lymph Node Involvement in Small (< 2 cm) Appendiceal Neuroendocrine Tumors. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 227(4), E57.
- Selecting incision-dominant cases for robotic liver resection: towards outpatient hepatectomy with rapid recovery
  Melstrom, L. G., Warner, S. G., Woo, Y., Sun, V., Lee, B., Singh, G., & Fong, Y. (2018). Selecting incision-dominant cases for robotic liver resection: towards outpatient hepatectomy with rapid recovery. HEPATOBILIARY SURGERY AND NUTRITION, 7(2), 77–84.
- Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)? (vol 24, pg 2122, 2017)
  Whealon, M. D., Gahagan, J. V., Sujatha-Bhaskar, S., O'Leary, M. P., Selleck, M., Dumitra, S., … Pigazzi, A. (2017). Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)? (vol 24, pg 2122, 2017). ANNALS OF SURGICAL ONCOLOGY, 24, S690.
- Efficacy of Self-Expandable Metallic Stents for Colonic and Extracolonic Malignant Obstruction
  Lin, J. L., David, D., & Lee, B. (2017). Efficacy of Self-Expandable Metallic Stents for Colonic and Extracolonic Malignant Obstruction. GASTROINTESTINAL ENDOSCOPY, 85(5), AB401.
- Wireless Real-Time Program Successfully Monitors Recovery after Major Abdominal Surgery
  Dumitra, S., Sun, V., Ruel, N. H., Lee, B., Woo, Y., Melstrom, L. G., … Fong, Y. (2016). Wireless Real-Time Program Successfully Monitors Recovery after Major Abdominal Surgery. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 223(4), E49.
- Prognostic significance of lymph node sampling in node-negative appendiceal carcinoids.
  Raoof, M., Dumitra, S., Singh, G., Fong, Y., & Lee, B. (2016). Prognostic significance of lymph node sampling in node-negative appendiceal carcinoids. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
- Assessment of the Double-Staple Technique for Esophagoenteric Anastomosis in Gastric Cancer
  Choi, A. H., Arrington, A., Falor, A., Nelson, R. A., Lew, M., Chao, J., … Kim, J. (2016). Assessment of the Double-Staple Technique for Esophagoenteric Anastomosis in Gastric Cancer. JOURNAL OF GASTROINTESTINAL SURGERY, 20(4), 688–92.
- Hospital Readmission Following Surgery for Gastric Cancer: Frequency, Timing, Etiologies, and Survival
  Merchant, S. J., Ituarte, P. H. G., Choi, A., Sun, V., Chao, J., Lee, B., & Kim, J. (2015). Hospital Readmission Following Surgery for Gastric Cancer: Frequency, Timing, Etiologies, and Survival. JOURNAL OF GASTROINTESTINAL SURGERY, 19(10), 1769–81.
- Impact of Gastric Cancer Resection on Body Mass Index
  Luu, C., Arrington, A. K., Falor, A., Kim, J., Lee, B., Nelson, R., … Kim, J. (2014). Impact of Gastric Cancer Resection on Body Mass Index. AMERICAN SURGEON, 80(10), 1022–25.
- Effectiveness of capecitabine plus oxaliplatin for advanced colon cancer: A public hospital experience
  Luu, C., Velasquez, J., Kaji, A., Stabile, B. E., Petrie, B. A., Kumar, R., … Lee, B. (2013). Effectiveness of capecitabine plus oxaliplatin for advanced colon cancer: A public hospital experience. JOURNAL OF CLINICAL ONCOLOGY, 31(4).
- Evaluating malignant intraductal papillary mucinous neoplasm: A population-based study
  Luu, C., Nelson, R. A., Lee, B., Singh, G., & Kim, J. (2013). Evaluating malignant intraductal papillary mucinous neoplasm: A population-based study. JOURNAL OF CLINICAL ONCOLOGY, 31(4).
- A public hospital experience with young gastric cancer patients
  Goldner, B. S., Velasquez, J., Stabile, B. E., Chen, S. L., Kim, J., Lin, M., … Lee, B. (2013). A public hospital experience with young gastric cancer patients. JOURNAL OF CLINICAL ONCOLOGY, 31(4).
- Incidence of Inflammatory Breast Cancer in Women, 1992-2009, United States
  Goldner, B., Behrendt, C. E., Schoellhammer, H. F., Lee, B., & Chen, S. L. (2014). Incidence of Inflammatory Breast Cancer in Women, 1992-2009, United States. ANNALS OF SURGICAL ONCOLOGY, 21(4), 1267–70.
- Liver Resection Using a Four-Prong Radiofrequency Transection Device
  Wagman, L. D., Lee, B., Castillo, E., El-Bayar, H., & Lai, L. (2009). Liver Resection Using a Four-Prong Radiofrequency Transection Device. AMERICAN SURGEON, 75(10), 991–94.
- Totally Laparoscopic Gastric Resection with Extended Lymphadenectomy for Gastric Adenocarcinoma
  Guzman, E. A., Pigazzi, A., Lee, B., Soriano, P. A., Nelson, R. A., Paz, I. B., … Ellenhorn, J. D. I. (2009). Totally Laparoscopic Gastric Resection with Extended Lymphadenectomy for Gastric Adenocarcinoma. ANNALS OF SURGICAL ONCOLOGY, 16(8), 2218–23.
- Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors.
  Blakely, A. M., Raoof, M., Ituarte, P. H., Fong, Y., Singh, G., & Lee, B. (2019). Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine Tumors. Annals of Surgical Oncology, 26(12), 4008–15.
- Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?
  Wiseman, J. T., Kimbrough, C., Beal, E. W., Zaidi, M. Y., Staley, C. A., Grotz, T., … Cloyd, J. M. (2019). Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? Annals of Surgical Oncology.
- Appendiceal Cancer: Comparison of Patients Presenting Initially for Definitive Operation with Those Presenting after Prior Non-Curative Resection
  Blakely, A. M., LaRocca, C. J., Eng, O. S., Ituarte, P. H., Lee, B., & Raoof, M. (2019). Appendiceal Cancer: Comparison of Patients Presenting Initially for Definitive Operation with Those Presenting after Prior Non-Curative Resection. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), S255–S256.
- Synchronous Small Bowel Neuroendocrine Tumors with Liver Metastases: Are Combined Resections Safe?
  De Andrade, J. P., Lafaro, K. J., Ituarte, P. H. G., Lee, B., & Singh, G. (2019). Synchronous Small Bowel Neuroendocrine Tumors with Liver Metastases: Are Combined Resections Safe? JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), E15.
- Neuroendocrine Tumors of Meckel's Diverticula: Rare but Fare Well
  De Andrade, J. P., Blakely, A. M., Nguyen, A. H., Ituarte, P. H. G., Warner, S. G., Melstrom, L. G., … Singh, G. (2019). Neuroendocrine Tumors of Meckel's Diverticula: Rare but Fare Well. AMERICAN SURGEON, 85(10), 1125–28.
- Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study.
  Lee, T. C., Wima, K., Sussman, J. J., Ahmad, S. A., Cloyd, J. M., Ahmed, A., … Patel, S. H. (2019). Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Trends and outcomes of robotic surgery for gastrointestinal (GI) cancers in the USA: maintaining perioperative and oncologic safety.
  Konstantinidis, I. T., Ituarte, P., Woo, Y., Warner, S. G., Melstrom, K., Kim, J., … Melstrom, L. G. (2019). Trends and outcomes of robotic surgery for gastrointestinal (GI) cancers in the USA: maintaining perioperative and oncologic safety. Surgical Endoscopy.
- The Association of Tumor Laterality and Survival After Cytoreduction for Colorectal Carcinomatosis.
  Blakely, A. M., Lafaro, K. J., Eng, O. S., Ituarte, P. H., Fakih, M., Lee, B., & Raoof, M. (2019). The Association of Tumor Laterality and Survival After Cytoreduction for Colorectal Carcinomatosis. The Journal of Surgical Research, 248, 20–27.
- Pilot study of a telehealth perioperative physical activity intervention for older adults with cancer and their caregivers.
  Lafaro, K. J., Raz, D. J., Kim, J. Y., Hite, S., Ruel, N., Varatkar, G., … Sun, V. (2019). Pilot study of a telehealth perioperative physical activity intervention for older adults with cancer and their caregivers. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer.
- Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review.
  Beal, E. W., Suarez-Kelly, L. P., Kimbrough, C. W., Johnston, F. M., Greer, J., Abbott, D. E., … Cloyd, J. M. (2020). Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review. Journal of Clinical Medicine, 9(3).
- Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study.
  Powers, B. D., Felder, S., Veerapong, J., Baumgartner, J. M., Clarke, C., Mogal, H., … Dineen, S. P. (2020). Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study. Annals of Surgical Oncology.
- The Chicago Consensus on peritoneal surface malignancies: Standards
  Plana, A., Izquierdo, F. J., Schuitevoerder, D., Abbott, D. E., Abdel-Misih, S., Ahrendt, S. A., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Standards. CANCER.
- The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms
  Schuitevoerder, D., Plana, A., Izquierdo, F. J., Votanopoulos, K., Cusack, J. C., Bijelic, L., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. CANCER.
- The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma
  Schuitevoerder, D., Izquierdo, F. J., Plana, A., Nash, G. M., Fernandez, L. J., Kluger, M. D., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. CANCER.
- The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms
  Hoppenot, C., Schuitevoerder, D., Izquierdo, F. J., Plana, A., Pothuri, B., Yamada, S. D., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms. CANCER.
- The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases
  Izquierdo, F. J., Schuitevoerder, D., Plana, A., Sherman, S. K., White, M. G., Baumgartner, J. M., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. CANCER.
- The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations
  Plana, A., Izquierdo, F. J., Schuitevoerder, D., Lambert, L. A., Micic, D., Deneve, J. L., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. CANCER.
- The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors
  Schuitevoerder, D., Plana, A., Izquierdo, F. J., Lambert, L. A., Keutgen, X. M., Deneve, J. L., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors. CANCER.
- The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases
  Izquierdo, F. J., Schuitevoerder, D., Plana, A., Eng, O. S., Sherman, S. K., Badgwell, B., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases. CANCER.
- The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors
  Izquierdo, F. J., Plana, A., Schuitevoerder, D., Hayes-Jordan, A., Deneve, J. L., Al-Kasspooles, M., … Turaga, K. K. (2020). The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. CANCER.
- Does Lymphadenectomy Extent Impact Survival in Small Bowel Neuroendocrine Tumors?
  De Andrade, J., Blakely, A., Nguyen, A., Ituarte, P., Li, D., Lee, B., & Singh, G. (2020). Does Lymphadenectomy Extent Impact Survival in Small Bowel Neuroendocrine Tumors? PANCREAS, 49(3), 467.
- NETS Arising in a Meckel's Diverticulum: Do They Behave Differently Than Ileal NETS?
  De Andrade, J., Blakely, A., Nguyen, A., Singh, G., Lee, B., & Ituarte, P. (2020). NETS Arising in a Meckel's Diverticulum: Do They Behave Differently Than Ileal NETS? PANCREAS, 49(3), 466–67.
- Gastro-Entero-Pancreatic Neuroendocrine Tumors in Young Adults - Fare Better Than Older Patients
  Nguyen, A., Stewart, C., Larocca, C., De Andrade, J., Ituarte, P., Lee, B., … Singh, G. (2020). Gastro-Entero-Pancreatic Neuroendocrine Tumors in Young Adults - Fare Better Than Older Patients. PANCREAS, 49(3), 481–82.
- The Chicago Consensus guidelines for peritoneal surface malignancies: Introduction
  Turaga, K. K., Ahuja, N., Alexander, H. R., Abbott, D. E., Badgwell, B., Baumgartner, J. M., … Bartlett, D. L. (2020). The Chicago Consensus guidelines for peritoneal surface malignancies: Introduction. CANCER.
- National postoperative and oncologic outcomes after pelvic exenteration for T4b rectal cancer.
  Konstantinidis, I. T., Lee, B., Trisal, V., Paz, I., Melstrom, K., Sentovich, S., … Raoof, M. (2020). National postoperative and oncologic outcomes after pelvic exenteration for T4b rectal cancer. Journal of Surgical Oncology.
- Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways.
  Eng, O. S., Blakely, A. M., Lafaro, K. J., Fournier, K. F., Fackche, N. T., Johnston, F. M., … Raoof, M. (2020). Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. Journal of Surgical Oncology.
- Predictors of Nonhome Discharge after Cytoreductive Surgery and HIPEC.
  Kubi, B., Gunn, J., Fackche, N., Cloyd, J. M., Abdel-Misih, S., Grotz, T., … Greer, J. B. (2020). Predictors of Nonhome Discharge after Cytoreductive Surgery and HIPEC. The Journal of Surgical Research, 255, 475–85.
- Prognostic impact of tumor location in resected gallbladder cancer: A national cohort analysis.
  Lafaro, K., Blakely, A. M., Melstrom, L. G., Warner, S. G., Lee, B., Singh, G., … Raoof, M. (2020). Prognostic impact of tumor location in resected gallbladder cancer: A national cohort analysis. Journal of Surgical Oncology.
- Whole transcriptome changes correlate to exceptional ovarian cancer responders: A sub-analysis of a HIPEC Phase I trial.
  Dellinger, T. H., Wu, X., Cho, H., Liang, W. S., Han, E. S., Wakabayashi, M. T., … Rodriguez-Rodriguez, L. (2020). Whole transcriptome changes correlate to exceptional ovarian cancer responders: A sub-analysis of a HIPEC Phase I trial. JOURNAL OF CLINICAL ONCOLOGY, 38(15).
- CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative.
  Roife, D., Powers, B. D., Zaidi, M. Y., Staley, C. A., Cloyd, J. M., Ahmed, A., … Dineen, S. P. (2020). CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative. Annals of Surgical Oncology.
- Prognostic Significance of Tumor Markers in Low Grade Appendiceal Mucinous Neoplasms: A Multi-Institutional Collaborative
  Nizam, W., Cloyd, J., Dineen, S., Patel, S. H., Mogal, H. D., Abbott, D. E., … Greer, J. (2020). Prognostic Significance of Tumor Markers in Low Grade Appendiceal Mucinous Neoplasms: A Multi-Institutional Collaborative. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 231(4), E210–E211.
- Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis.
  Kubi, B., Nudotor, R., Fackche, N., Nizam, W., Cloyd, J. M., Grotz, T. E., … Greer, J. B. (2021). Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis. Annals of Surgical Oncology.
- Regional lymph node sampling in hepatoma resection: insight into prognosis.
  Bergquist, J. R., Li, A. Y., Javadi, C. S., Lee, B., Norton, J. A., Poultsides, G. A., … Visser, B. C. (2021). Regional lymph node sampling in hepatoma resection: insight into prognosis. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
- The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative.
  Fackche, N., Schmocker, R. K., Kubi, B., Cloyd, J. M., Ahmed, A., Grotz, T., … Greer, J. B. (2021). The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Tumor response score with neoadjuvant FLOT versus FOLFOX in gastric cancer patients: Results from a United States-based cohort.
  De Andrade, J. P., Ahn, H. S., Chao, J., Melstrom, L. G., Paz, I. B., Fong, Y., … Woo, Y. (2020). Tumor response score with neoadjuvant FLOT versus FOLFOX in gastric cancer patients: Results from a United States-based cohort. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Cancer Regional Therapy HAI, HIPEC, HILP, ILI, PIPAC, and Beyond Preface
  Fong, Y., Gamblin, T. C., Han, E. S., Lee, B., & Zager, J. S. (2020). Cancer Regional Therapy HAI, HIPEC, HILP, ILI, PIPAC, and Beyond Preface. CANCER REGIONAL THERAPY: HAI, HIPEC, HILP, ILI, PIPAC, AND BEYOND, XI-XIII.
- Complications of Cytoreductive Surgery and HIPEC
  Blakely, A. M., & Lee, B. (2020). Complications of Cytoreductive Surgery and HIPEC. CANCER REGIONAL THERAPY: HAI, HIPEC, HILP, ILI, PIPAC, AND BEYOND, 179–188.
- Safety and tolerability of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in ovarian cancer: clinical results from a phase I trial
  Dellinger, T., Han, E., Lin, W.-C., Kebria, M., Hakim, A., de Leon, M., … Wakabayashi, M. (2021). Safety and tolerability of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in ovarian cancer: clinical results from a phase I trial. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE.
- Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative.
  Nizam, W., Fackche, N., Pessoa, B., Kubi, B., Cloyd, J. M., Grotz, T., … Greer, J. B. (2021). Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
- Surgical resection of leiomyosarcoma of the inferior vena cava: A case series and literature review.
  Zhou, M., Javadi, C., Charville, G. W., Bui, N. Q., Harris, E. J., Poultsides, G. A., … Ganjoo, K. N. (2021). Surgical resection of leiomyosarcoma of the inferior vena cava: A case series and literature review. Surgical Oncology, 39, 101670.
- Single-Cell Transcriptomic Analysis of a Patient with Metastatic Appendiceal Adenocarcinoma: A Stem or Crypt Cell-Like Neoplasm?
  Ayala, C., Grimes, S. M., Lee, B., & Ji, H. (2021). Single-Cell Transcriptomic Analysis of a Patient with Metastatic Appendiceal Adenocarcinoma: A Stem or Crypt Cell-Like Neoplasm? JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases.
  Sun, B. J., & Lee, B. (2022). Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases. Cancers, 14(3).
- Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer.
  Dellinger, T. H., Han, E. S., Raoof, M., Lee, B., Wu, X., Cho, H., … Rodriguez-Rodriguez, L. (2022). Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer. JCO Precision Oncology, 6, e2100239.
- Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best?
  Javadi, C., Chang, J., Forgo, E., Ahmad, M. U., Fisher, G. A., Chang, D. T., … Poultsides, G. A. (2022). Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best? ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Mucinous Epithelial Cell Secretion Drives Mucinous Ascites Formation in Pseudomyxoma Peritonei Patients
  Ayala, C., Sathe, A., Grimes, S., Zhao, L., Bai, X., Poultsides, G., … Ji, H. (2022). Mucinous Epithelial Cell Secretion Drives Mucinous Ascites Formation in Pseudomyxoma Peritonei Patients. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery.
  Deng, H., Eftekhari, Z., Carlin, C., Veerapong, J., Fournier, K. F., Johnston, F. M., … Raoof, M. (2022). Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery. JAMA Network Open, 5(5), e2212930.
- Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.
  Kubi, B., Nudotor, R., Fackche, N., Rowe, J., Cloyd, J. M., Ahmed, A., … Greer, J. B. (2022). Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC. Journal of Surgical Oncology.
- Improving online resources for cytoreductive surgery and HIPEC by engaging patients.
  Rouhi, A. D., Muhammad, H. A., Lee, B., & Eng, O. S. (2023). Improving online resources for cytoreductive surgery and HIPEC by engaging patients. Journal of Surgical Oncology.
- Heated Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer-Restarting the Fire.
  Daniel, S. K., & Lee, B. (2023). Heated Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer-Restarting the Fire. JAMA Surgery.
- Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.
  Winicki, N. M., Radomski, S. N., Florissi, I. S., Cloyd, J. M., Gutta, G., Grotz, T. E., … Greer, J. B. (2023). Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. Annals of Surgical Oncology.
- Efficacy of Surgical Management of Malignant Bowel Obstruction on Preventing Hospital Readmission - Experience of a Tertiary Care Center
  Sun, B. J., Ayala, C. I., Einkauf, K. B., Xu, N., Yue, T. M., & Lee, B. (2023). Efficacy of Surgical Management of Malignant Bowel Obstruction on Preventing Hospital Readmission - Experience of a Tertiary Care Center. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
  Sun, B. J., Li, A., Alobuia, W., Hur, D., Daniel, S. K., Kirane, A. R., … Lee, B. (2023). Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- A National Assessment of Disparities Between Rural-Urban Patients with Surgically Managed Advanced Appendiceal Cancer
  Li, A. Y., Sun, B. J., Tran, T. B., Lee, B., & Eng, O. S. (2023). A National Assessment of Disparities Between Rural-Urban Patients with Surgically Managed Advanced Appendiceal Cancer. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Evaluation of Content Quality for Patients Searching YouTube for Videos on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  Muhammad, H., Kadri, H., Narayan, R., & Lee, B. (2023). Evaluation of Content Quality for Patients Searching YouTube for Videos on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Outcomes of Procedural-Based Palliation for Malignant Bowel Obstruction
  Sun, B. J., Xu, N., Yue, T. M., Einkauf, K. B., & Lee, B. (2023). Outcomes of Procedural-Based Palliation for Malignant Bowel Obstruction. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Impact of Successful Implementation of an Enhanced Recovery After Surgery Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
  Sun, B. J., Yue, T. M., Xu, N., Fowler, C., & Lee, B. (2023). Impact of Successful Implementation of an Enhanced Recovery After Surgery Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology.
- Evaluation of Content Quality for Patients Searching YouTube for Videos on Cytoreductive Surgery and Hyperthermic Intraperitoneal Peritoneal Surgery.
  Muhammad, H. A., Kadri, H., Narayan, R. R., & Lee, B. (2023). Evaluation of Content Quality for Patients Searching YouTube for Videos on Cytoreductive Surgery and Hyperthermic Intraperitoneal Peritoneal Surgery. Annals of Surgical Oncology.
- Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer.
  Senguttuvan, R. N., Santiago, N. L., Han, E. S., Lee, B., Lee, S., Lin, W.-C., … Dellinger, T. H. (2023). Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer. Annals of Surgical Oncology.
- ASO Author Reflections: The Potential of ERAS in Standardizing Care for Patients Undergoing CRS-HIPEC.
  Sun, B. J., & Lee, B. (2023). ASO Author Reflections: The Potential of ERAS in Standardizing Care for Patients Undergoing CRS-HIPEC. Annals of Surgical Oncology.
- ASO Visual Abstract: Impact of Successful Implementation of an Enhanced Recovery After Surgery (ERAS) Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
  Sun, B. J., Yue, T. M., Xu, N., Fowler, C., & Lee, B. (2023). ASO Visual Abstract: Impact of Successful Implementation of an Enhanced Recovery After Surgery (ERAS) Protocol for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC). Annals of Surgical Oncology.
- Interpersonal concerns of young adult surgical oncology patients with advanced cancer diagnoses: A mixed methods study
  Sun, B. J., Pang, E., & Lee, B. (2023). Interpersonal concerns of young adult surgical oncology patients with advanced cancer diagnoses: A mixed methods study. JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS.
- Results of the First Phase I PIPAC Trial in the United States: Braving the Storm.
  Sun, B. J., & Lee, B. (2023). Results of the First Phase I PIPAC Trial in the United States: Braving the Storm. Annals of Surgical Oncology.
- ASO Visual Abstract: Neighborhood Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.
  Winicki, N. M., Radomski, S. N., Florissi, I. S., Cloyd, J. M., Gutta, G., Grotz, T. E., … Greer, J. B. (2023). ASO Visual Abstract: Neighborhood Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. Annals of Surgical Oncology.
- ASO Visual Abstract: Evaluation of Content Quality for Patients Searching YouTube for Videos on Cytoreductive Surgery and Hyperthermic Intraperitoneal Peritoneal Chemotherapy.
  Muhammad, H. A., Kadri, H., Narayan, R. R., & Lee, B. (2023). ASO Visual Abstract: Evaluation of Content Quality for Patients Searching YouTube for Videos on Cytoreductive Surgery and Hyperthermic Intraperitoneal Peritoneal Chemotherapy. Annals of Surgical Oncology.
- ASO Visual Abstract: Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer.
  Senguttuvan, R. N., Santiago, N. L., Han, E. S., Lee, B., Lee, S., Lin, W.-C. C., … Dellinger, T. H. (2023). ASO Visual Abstract: Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer. Annals of Surgical Oncology.
- GITR and TIGIT immunotherapy provokes divergent multi-cellular responses in the tumor microenvironment of gastrointestinal cancers.
  Sathe, A., Ayala, C., Bai, X., Grimes, S. M., Lee, B., Kin, C., … Ji, H. P. (2023). GITR and TIGIT immunotherapy provokes divergent multi-cellular responses in the tumor microenvironment of gastrointestinal cancers. BioRxiv : the Preprint Server for Biology.
- Results of the First Phase I PIPAC Trial in the United States: Braving the Storm
  Sun, B. J., & Lee, B. (2023). Results of the First Phase I PIPAC Trial in the United States: Braving the Storm. ANNALS OF SURGICAL ONCOLOGY.
- Evaluation of Content Quality for Patients Searching YouTube for Videos on Cytoreductive Surgery and Hyperthermic Intraperitoneal Peritoneal Surgery
  Muhammad, H. A., Kadri, H., Narayan, R. R., & Lee, B. (2023). Evaluation of Content Quality for Patients Searching YouTube for Videos on Cytoreductive Surgery and Hyperthermic Intraperitoneal Peritoneal Surgery. ANNALS OF SURGICAL ONCOLOGY.
- The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer.
  Sun, B. J., Daniel, S. K., & Lee, B. (2023). The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer. Journal of Clinical Medicine, 12(20).
- PIPAC for Gastrointestinal Malignancies.
  Daniel, S. K., Sun, B. J., & Lee, B. (2023). PIPAC for Gastrointestinal Malignancies. Journal of Clinical Medicine, 12(21).
- GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers.
  Sathe, A., Ayala, C., Bai, X., Grimes, S. M., Lee, B., Kin, C., … Ji, H. P. (2023). GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers. Genome Medicine, 15(1), 100.
- Timing of Palliative Care Consultation in Malignant Bowel Obstruction Management Decreases Hospital Readmission
  Sun, B., Yue, T., Xu, N., Einkauf, K. B., & Lee, B. (2023). Timing of Palliative Care Consultation in Malignant Bowel Obstruction Management Decreases Hospital Readmission. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Timing of Palliative Care Consultation in Malignant Bowel Obstruction Management Decreases Hospital Readmission
  Sun, B., Yue, T., Xu, N., Einkauf, K. B., & Lee, B. (2023). Timing of Palliative Care Consultation in Malignant Bowel Obstruction Management Decreases Hospital Readmission. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Patient-Reported Resource Needs of Young Adult Surgical Oncology Patients with Advanced Cancer Diagnoses: A Qualitative Analysis
  Sun, B., Pang, E. M., & Lee, B. (2023). Patient-Reported Resource Needs of Young Adult Surgical Oncology Patients with Advanced Cancer Diagnoses: A Qualitative Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. LIPPINCOTT WILLIAMS & WILKINS.
- Understanding the Caregiver Perspective: The Impact of Caring for Patients with Advanced Cancer.
  Sun, B. J., & Lee, B. (2024). Understanding the Caregiver Perspective: The Impact of Caring for Patients with Advanced Cancer. Annals of Surgical Oncology.
- Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
  Fackche, N. T., Schmocker, R. K., Nudotor, R., Kubi, B., Cloyd, J. M., Grotz, T. E., … Greer, J. B. (2024). Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative. Annals of Surgical Oncology.
- Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
  Yue, T. M., Sun, B. J., Xu, N., Ohkuma, R., Fowler, C., & Lee, B. (2024). Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC). Annals of Surgical Oncology.
- ASO Author Reflections: Integrating Multimodal Pain Management Protocols into ERAS for Patients Undergoing CRS-HIPEC.
  Yue, T., Sun, B., & Lee, B. (2024). ASO Author Reflections: Integrating Multimodal Pain Management Protocols into ERAS for Patients Undergoing CRS-HIPEC. Annals of Surgical Oncology.
- Distal Pancreatectomy With and Without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy
  Daniel, S. K., Hironaka, C., Ahmad, M. U., Delitto, D., Dua, M., Lee, B., … Poultsides, G. (2024). Distal Pancreatectomy With and Without Celiac Axis Resection for Adenocarcinoma: A Comparison in the Era of Neoadjuvant Therapy. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Single cell pharmacogenic pipeline identifies novel opportunities in uterine leiomyosarcoma
  Daniel, S. K., Foster, D., Nosrati, F., Korah, M., Fallah, M., Sun, B. J., … Delitto, D. (2024). Single cell pharmacogenic pipeline identifies novel opportunities in uterine leiomyosarcoma. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Single cell transcriptomic analysis reveals differences between primary appendiceal tumors
  Ayala, C. I., Sathe, A., Bai, X., Grimes, S., Lee, B., & Ji, H. P. (2024). Single cell transcriptomic analysis reveals differences between primary appendiceal tumors. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Single cell transcriptomic analysis of malignant peritoneal mesothelioma: finding the tumor cells?
  Ayala, C. I., Sathe, A., Bai, X., Grimes, S., Lee, B., & Li, H. P. (2024). Single cell transcriptomic analysis of malignant peritoneal mesothelioma: finding the tumor cells? ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- Initial Multivisceral Resection for Retroperitoneal Liposarcoma Does Not Predict Improved Outcomes After Recurrence
  Sun, B. J., Yue, T. M., Nobuhara, C. K., Castro, S., Agolia, J. P., & Lee, B. (2024). Initial Multivisceral Resection for Retroperitoneal Liposarcoma Does Not Predict Improved Outcomes After Recurrence. ANNALS OF SURGICAL ONCOLOGY. SPRINGER.
- ASO Visual Abstract: Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
  Yue, T. M., Sun, B. J., Xu, N., Ohkuma, R., Fowler, C., & Lee, B. (2024). ASO Visual Abstract: Improved Postoperative Pain Management Outcomes After Implementation of Enhanced Recovery After Surgery (ERAS) Protocol for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC). Annals of Surgical Oncology.
- Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative
  Makris, E. A., Tran, T. B., Delitto, D. J., Lee, B., Ethun, C. G., Grignol, V., … Kirane, A. (2024). Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative. JOURNAL OF SURGICAL ONCOLOGY.
- Surgical Palliation for Malignant Bowel Obstruction in Preventing Hospital Readmission: Experience of a Tertiary Care Center.
  Sun, B. J., Yue, T. M., Xu, N., Ayala, C. I., & Lee, B. (2024). Surgical Palliation for Malignant Bowel Obstruction in Preventing Hospital Readmission: Experience of a Tertiary Care Center. Annals of Surgical Oncology.
- Factors Predicting Readmission and Mortality in Patients Admitted for Malignant Bowel Obstruction.
  Xu, N., Sun, B. J., Yue, T. M., & Lee, B. (2024). Factors Predicting Readmission and Mortality in Patients Admitted for Malignant Bowel Obstruction. The American Surgeon, 31348241250045.
- Surgical Deloyers procedure after left hemicolectomy in Gynecologic Oncology
  Lang, S. M., Lee, B., & Karam, A. (2024). Surgical Deloyers procedure after left hemicolectomy in Gynecologic Oncology. GYNECOLOGIC ONCOLOGY REPORTS, 53.
- Palliative Intervention for Malignant Bowel Obstruction Comes at a Cost: A National Inpatient Study.
  Sun, B. J., Tennakoon, L., Spain, D. A., & Lee, B. (2024). Palliative Intervention for Malignant Bowel Obstruction Comes at a Cost: A National Inpatient Study. The American Surgeon, 31348241256083.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials

CytoreductiveSurgery & HIPEC W/Gemcitabine+Chemotherapy W/Dacarbazine in Uterine Leiomyosarcoma

Specializing In

Adrenal Tumors
Appendix Cancer
Desmoid Tumor
Esophageal Cancer
Gastrectomy
Gastrointestinal Oncology
Hepatobiliary Surgery
HIPEC Therapy
Laparoscopic Surgery
Laparoscopy
Liver Cancer
Neuroendocrine Tumors

Pancreas Conditions
Pancreatic Cancer
Pancreatic Cysts
Pancreatic Surgery
Peritoneal Mesothelioma
Robotic Surgery
Sarcoma
Small Bowel Tumors
Stomach Cancer
Surgery for Sarcoma
Surgical Oncology

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Gastrointestinal (GI) Cancer Program in San Jose San Jose, CA

San Jose, CA

Gastrointestinal (GI) Cancer Program in San Jose

2589 Samaritan Dr

San Jose , CA 95124

(650) 498-6000

More Clinic Information

Sarcoma Program in South Bay San Jose, CA

San Jose, CA

Sarcoma Program in South Bay

2589 Samaritan Dr

San Jose , CA 95124

+1 (833) 444-7622

More Clinic Information

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

875 Blake Wilbur Dr

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

Cancer Center in South Bay San Jose, CA

San Jose, CA

Cancer Center in South Bay

2589 Samaritan Dr

San Jose , CA 95124

+1 (833) 444-7622

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(27 Ratings)

Overall Rating

4.8/5

View Ratings by Category

4.9/5

Friendliness

4.9/5

Explanations

4.8/5

Listens

4.9/5

Care provider's efforts to include you in decisions about your care

4.7/5

Recommended to others

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(116 reviews)

Dr Lee is a wonderful Dr who cares about his patients, there is never a doubt in that. He's super informative and compassionate. Thank you for being empathetic during my visit.

Nov 2024

•

Verified SHC Patient

Compassionate, physician who clearly explains without using jargon. I canâ€™t imagine going through my illness without his care and guidance.

Nov 2024

•

Verified SHC Patient

I am very appreciative that Dr. Lee has given me hope for this new procedure I may be a candidate for...

Nov 2024

•

Verified SHC Patient

Exceptional Expertise

Sep 2024

•

Verified SHC Patient

Thank you!!!!!!!!!!

Sep 2024

•

Verified SHC Patient

Dr. Lee gave us a clear interpretation of the CAT scan and explained why he recommended continuation of chemotherapy rather than surgery at this time.

Sep 2024

•

Verified SHC Patient

Dr. Lee answered all my questions and explained what my next steps would be before my future procedure.

Aug 2024

•

Verified SHC Patient

Great Doctor!

Aug 2024

•

Verified SHC Patient

He is an excellent physician--listening, understanding and explaining, all to my complete satisfaction.

Jul 2024

•

Verified SHC Patient

I appreciate Dr. Lee's patience with my questions and interruptions. I knew from another of his patients what to expect in terms of his personality, which may not be the most effusive. But honestly, Dr. Lee seemed very genuine and straightforward, which I appreciate. I am confident that Dr. Lee is the right choice for my treatment.

Jul 2024

•

Verified SHC Patient

Dr. Bryne Lee and his outstanding staff did a tremendous job in taking the cancer in my stomach. He also followed up with an in person visit

Jul 2024

•

Verified SHC Patient

Thank you, Dr Lee!

Jul 2024

•

Verified SHC Patient

Dr. Lee seems to be a very good surgeon. My experience was was major, but I survived !

Jun 2024

•

Verified SHC Patient

Great Doctor!

May 2024

•

Verified SHC Patient

Extremely professional, thorough, patient and caring about me as his patient. Iâ€™m very pleased to have been recommended to him.

May 2024

•

Verified SHC Patient

Wonderful support

May 2024

•

Verified SHC Patient

Dr Lee is a very good communicator. He answers questions and asks questions.

May 2024

•

Verified SHC Patient

Wonderful person and fantastic doctor.

Apr 2024

•

Verified SHC Patient

Very personable

Apr 2024

•

Verified SHC Patient

I feel so fortunate to have Dr. Lee looking out for me and any nexts steps moving forward. He is a very good communicator, extremely thorough, and his team is compassionate and doesnâ€™t miss a beat. I researched the kind of Dr I needed and found Dr Lee and knew his expertise was what was needed and I feel extremely fortunate that he could see me. Whether I receive confirmation that everything is ok, or find that additional treatments are needed, I feel 100% confident that my care is being managed with utmost regard for my health, and coordination of care like nothing I have ever experienced. Thank you.

Mar 2024

•

Verified SHC Patient

Excellent physician.

Feb 2024

•

Verified SHC Patient

Heâ€™s great

Feb 2024

•

Verified SHC Patient

Exceptional Doctor

Feb 2024

•

Verified SHC Patient

Byrne Lee is a genius, a rare talent, and a compassionate man â€” an invaluable gem.

Feb 2024

•

Verified SHC Patient

good doctor

Jan 2024

•

Verified SHC Patient

A very nice person

Nov 2023

•

Verified SHC Patient

I thanked Dr Lee for his awesome surgery. My abdomen is still clear of cancer two years after HIPEC surgery. Dr Lee is a rockstar.

Nov 2023

•

Verified SHC Patient

Extremely professional

Nov 2023

•

Verified SHC Patient

Superior Surgeon !

Oct 2023

•

Verified SHC Patient

Dr. Byrne Lee is an amazing doctor.. He cares about his patients and is very thorough in answering and addressing any and all questions or concerns.. He's easy to talk to, and makes the patient feel comfortable and confident..

Oct 2023

•

Verified SHC Patient

He was straight forward, clear, and I could understand him very well.

Oct 2023

•

Verified SHC Patient

See comments beforehand. Dr. Byrne Lee is an outstanding an companionate doctor. I have referred a clientâ€™s niece to him who has stomach cancer.

Oct 2023

•

Verified SHC Patient

He is very nice

Sep 2023

•

Verified SHC Patient

Dr Byrne Lee is a very attentive person. He seems to really care about the progress I have been making in my recovery. He visited me often in the hospital. He and his team have been helpful with the problems I've been having since I was sent home.

Aug 2023

•

Verified SHC Patient

Dr. Lee answers any questions I have. I donâ€™t feel rushed. I trust him to make the right decisions about my health. I believe he has my best interests at heart.

Jul 2023

•

Verified SHC Patient

Grateful to have the opportunity to receive the care and attention of his specialty, Professional medical experience and expertise.

Jul 2023

•

Verified SHC Patient

Dr Lee came highly recommended & I have been very pleased by his deep knowledge of my condition & recommendations for next steps.

Jul 2023

•

Verified SHC Patient

I would like to say thank you to doctor Byrne Lee.

Jul 2023

•

Verified SHC Patient

Thank you for the information

Jul 2023

•

Verified SHC Patient

I am very thankful to Dr. Lee and his team for the care I received.

May 2023

•

Verified SHC Patient

Very impressed with his manner, knowledge, and thoughtfulness. I went into the call with the expectation that his role would be to provide a second opinion regarding a surgical procedure that had been recommended by another doctor. During the course of the conversation it became clear that Dr. Lee is the right surgeon to perform the surgery.

May 2023

•

Verified SHC Patient

Dr. Lee is fantastic

May 2023

•

Verified SHC Patient

Video visit Dr, Lee, was real good , he did take the time to explain all my questions Thank Dr. Lee .

May 2023

•

Verified SHC Patient

I herd that he is the best of the best and I look forward to Dr. Lee taking care of me.

May 2023

•

Verified SHC Patient

He was prepared, thorough and answered all my questions.

Apr 2023

•

Verified SHC Patient

Thoughtful and reassuring discussion of my concerns

Apr 2023

•

Verified SHC Patient

Extremely helpful

Apr 2023

•

Verified SHC Patient

He seems like a nice doctor. He didn't rush the visit & answered all my questions.

Apr 2023

•

Verified SHC Patient

He is a great doctor

Mar 2023

•

Verified SHC Patient

Heâ€™s a great doctor.

Mar 2023

•

Verified SHC Patient

Good Doctor, very calming and knowledgeable.

Mar 2023

•

Verified SHC Patient

Heâ€™s a good doctor.

Feb 2023

•

Verified SHC Patient

He is very professional, respectful, and knowledgeable. I completely trust him with my care and recommendations.

Feb 2023

•

Verified SHC Patient

Seems to be very well-versed in all components of his specialty, engenders trust in his capabilities.

Feb 2023

•

Verified SHC Patient

Dr.Lee was wonderful and we talked about our future appointments and topics that would be discussed. Wonderful doctor to have on my team.

Jan 2023

•

Verified SHC Patient

I had a very positive impression of Dr Lee.

Jan 2023

•

Verified SHC Patient

I am grateful to Dr. Lee for the time he takes to read and/or review the test information regarding my health. Also he makes my visits feel important and well prepared for me.

Jan 2023

•

Verified SHC Patient

Dr Lee was very personable and reassuring in his responses to me. I did not feel hurried or rushed. He was interested in and addressed all of my concerns. Gave me a good plan going forward and referred me on to another service for another problem outside of his expertise. Mostly because of poor systems and lack of communication I had received from past medical experiences I had lost faith and trust in some medical care I had received. I was so happy to have a face to face with someone who was interested in my thoughts and experiences about my disease process. I feel I can trust Dr Lee and that means everything. Most importantly I left the appointment feeling very connected and cared for.

Jan 2023

•

Verified SHC Patient

he explained the results well.

Dec 2022

•

Verified SHC Patient

He's a compassionate, highly qualified doctor. I'm so thankful that he's been in charge of my surgery and ongoing care.

Dec 2022

•

Verified SHC Patient

Dr Lee was easy to talk to and was very knowledgeable about my case. He is a good listener with patience and gave me hope with my illness.

Nov 2022

•

Verified SHC Patient

Best visit w an oncologist that Iâ€™ve had so far during my journey

Oct 2022

•

Verified SHC Patient

Dr, Lee is a kind, compassionate practitioner and a most skilled surgeon. I feel so fortunate to have had him perform my cancer surgery. He is extremely thorough in his follow-up visits and addresses all my concerns, even those not directly related to my surgery. He alerts me when it's time to involve other specialists, then reviews their findings to contribute to my overall health. Dr Lee is simply the best!

Oct 2022

•

Verified SHC Patient

Dr. Lee and Jenny were professional, friendly and had good words of advise. I am happy and honored to have them on my health team.

Oct 2022

•

Verified SHC Patient

Very professional yet considerate and empathetic

Oct 2022

•

Verified SHC Patient

He was very attentive

Sep 2022

•

Verified SHC Patient

Great Doctor, listens to my concerns and answers them.

Sep 2022

•

Verified SHC Patient

He is being very meticulous in monitoring my cancer.

Sep 2022

•

Verified SHC Patient

I feel Dr. Byrne Lee cares about his patients care and well-being, also very concerned. His bedside manner is exceptional. The care and understanding he shows comes from within. I'm very fortunate to have Dr. Lee as I go through this devastating time in my life. Dr. Lee is very attentive and through. With that being said, I know I made the right choice for my health care at Stanford. May God Bless the medical staff.

Sep 2022

•

Verified SHC Patient

Very courteous and professional. Clearly knowledgeable and made me feel very comfortable.

Aug 2022

•

Verified SHC Patient

Dr Lee answers my questions in understandable language.

Aug 2022

•

Verified SHC Patient

Awesome Doctor as usual

Aug 2022

•

Verified SHC Patient

Dr. Byrne Lee is an excellent doctor.

Aug 2022

•

Verified SHC Patient

he is terrific

Jul 2022

•

Verified SHC Patient

Very amazing

Jul 2022

•

Verified SHC Patient

Thank you so much

Jul 2022

•

Verified SHC Patient

Thank you.

Jul 2022

•

Verified SHC Patient

Dr Lee has been wonderful and I appreciate him and his team. He answers all of my questions. He has been fantastic. I couldn't have gotten better care. I am so grateful to have been referred to Dr Karam and Dr Lee from my local Oncology team

Jun 2022

•

Verified SHC Patient

He was very confident and knowledgable.

Jun 2022

•

Verified SHC Patient

Dr Lee was very understanding and thoughtful. He reviewed my outside medical records and provided me with medical information that I wanted to have.

Jun 2022

•

Verified SHC Patient

Always nice

Jun 2022

•

Verified SHC Patient

I wish he was little more talkative that might put the visit more friendly

Jun 2022

•

Verified SHC Patient

Dr. Byrne Lee strikes me as an intelligent, conscientious, empathetic, and compassionate doctor with excellent interpersonal skills.

May 2022

•

Verified SHC Patient

He is an excellent doctor. He saved my life from 4th stage of my cancer.

May 2022

•

Verified SHC Patient

Seemed caring. Listined to us . We feel comfertable with him.

Apr 2022

•

Verified SHC Patient

seems knowledgible

Mar 2022

•

Verified SHC Patient

Thank you Doctor, I appreciate your care.

Mar 2022

•

Verified SHC Patient

As usual, Dr. Lee was excellent, as was his resident, Dr. Wu.

Mar 2022

•

Verified SHC Patient

Dr. Lee and his support team are outstanding.

Mar 2022

•

Verified SHC Patient

Dr Lee is a superb physician and a wonderful man. I am very privileged to be under his care

Mar 2022

•

Verified SHC Patient

Dr. Bryne Lee is a wonderful doctor and surgeon that I highly recommend. I have received excellent care.

Feb 2022

•

Verified SHC Patient

a very pleasant meeting and discussion with Dr. Byrne Lee and Kristen, PA.

Feb 2022

•

Verified SHC Patient

Dr. Lee is an excellent doctor and I feel very grateful and blessed that he was my surgeon. He did a wonderful job.

Jan 2022

•

Verified SHC Patient

Dr. Lee is fabulous. I wish all doctors were like him.

Jan 2022

•

Verified SHC Patient

Very informative and concise.

Jan 2022

•

Verified SHC Patient

The video visit was very helpful. I believe everything was covered and I was given every opportunity to ask questions regarding my upcoming procedure.

Jan 2022

•

Verified SHC Patient

Everything was good!

Jan 2022

•

Verified SHC Patient

Dr is very professional & explains everything

Dec 2021

•

Verified SHC Patient

Visit was very informative.

Nov 2021

•

Verified SHC Patient

He is very kind and compassionate.

Nov 2021

•

Verified SHC Patient

Dr. Lee was very compassionate and clear on my prognosis and future treatment. This was very much appreciated.

Oct 2021

•

Verified SHC Patient

He was great!

Oct 2021

•

Verified SHC Patient

Thanks for all.

Oct 2021

•

Verified SHC Patient

Very informative and articulate and discussed issues in detail. Allowed me time for any questions or clarifications. Look forward to meeting Dr. Byrne Lee in person.

Oct 2021

•

Verified SHC Patient

He is very nice and easy to talk to

Sep 2021

•

Verified SHC Patient

Great demeanor, honest, thoughtful.

Sep 2021

•

Verified SHC Patient

Very helpful in answering my questions and explaining how and why he recommended the treatment to follow

Sep 2021

•

Verified SHC Patient

Best Doctor I could have!

Sep 2021

•

Verified SHC Patient

Dr Lee was thorough in his explanations and in answering our questions. He gave us lots of new information to digest. When I have questions, I will establish a Message link with Dr Lee.

Sep 2021

•

Verified SHC Patient

I feel so fortunate to have had the opportunity to meet with Dr. Lee. He was caring, patient, and extremely well informed about not only my condition, but also my specific scenario. It was validating and reassuring.

Aug 2021

•

Verified SHC Patient

Dr. Lee is an excellent physician

Aug 2021

•

Verified SHC Patient

Extremely professional and optimistic. He gave me hope.

Jul 2021

•

Verified SHC Patient

Very through and easy to understand explained things well

Jun 2021

•

Verified SHC Patient

What a fine doctor. I feel lucky to have discovered him. He made me feel heard and understood. I felt he saw me as a person, not just another patient. I feel a big sense of trust (as one should with a surgeon) and a sense of relief. Iâ€™ve already recommended him to a few people who are in a similar situation as I am.

May 2021

•

Verified SHC Patient

Dr. Lee always listens to what I have to say. He is very patient and kind that makes me comfortable. He also focuses on the big picture and answers all my questions.

Apr 2021

•

Verified SHC Patient

EXCELLENT

Apr 2021

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Byrne Lee, MD FACS

Surgical oncologist, General surgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

Gastrointestinal (GI) Cancer Program in San Jose San Jose, CA

Gastrointestinal (GI) Cancer Program in San Jose

Sarcoma Program in South Bay San Jose, CA

Sarcoma Program in South Bay

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

Cancer Center in South Bay San Jose, CA

Cancer Center in South Bay

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(116 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Byrne Lee, MD FACS

Surgical oncologist, General surgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Gastrointestinal (GI) Cancer Program in Palo Alto Palo Alto, CA

Gastrointestinal (GI) Cancer Program in Palo Alto

Gastrointestinal (GI) Cancer Program in San Jose San Jose, CA

Gastrointestinal (GI) Cancer Program in San Jose

Sarcoma Program in South Bay San Jose, CA

Sarcoma Program in South Bay

Sarcoma Program at Blake Wilbur Building Palo Alto, CA

Sarcoma Program at Blake Wilbur Building

Cancer Center in South Bay San Jose, CA

Cancer Center in South Bay

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(116 reviews)

Referring Physicians

PHYSICIAN HELPLINE